Preclinical researchers often utilize a variety of tumor models, including xenografts, orthotopic, and transgenic preparations. Imaging provides researchers the ability to detect, visualize and monitor the developing tumor over the course of a longitudinal study. Further, the images provide insights into tumorigenesis, as well as the efficacy of therapies and other interventions.
Ultrasound imaging is a non-invasive way to identify, track, and measure tumors; the 3D motor allows for tumor volumes to be calculated. A variety of organs can be imaged using ultrasound, making it possible to detect xenograft, orthotopic, and transgenic tumors in a variety of small animal models.
PET/CT Imaging combines the nuclear imaging of PET with the precision of an x-ray CT scanner to produce accurate anatomic renderings. PET/CT allows for the accurate visualization of tumor specific metabolism as well as the capability of distinguishing malignant cells from adjacent normal tissue based on established differences in biochemical activity.
The FIVE2 (ViewnVivo) is a miniaturised fluorescence endomicroscope platform that allows the preclinical researcher to acquire confocal images with unparalleled resolution and image quality. Molecular and microvascular events may be observed over the course of a longitudinal study.
M-Series™ Compact MRI
The M-SeriesTM Compact MRI systems allow the pre-clinical research to harness the power of MRI without the cost, complexity, and technical burden of conventional systems. MRI is the gold standard in soft tissue imaging facilitating tumor detection during a longitudinal study.
The Newton 7.0 is an innovative optical bioluminescence and fluorescence imaging system designed with the user in mind. It is ideal for in vivo, ex vivo and in vitro imaging applications, allowing for simultaneous imaging of multiple animals or samples at a time.